RxMx Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Sydney, NSW Australia
Total Funding:N/A
Industry:Health
Founded:2013
Lead Investor(s):N/A

Industry Ranking

Estimated Revenue & Financials

  • RxMx's estimated annual revenue is currently $18.9M per year.
  • RxMx's estimated revenue per employee is $270,000

Employee Data

  • RxMx has 70 Employees.
  • RxMx grew their employee count by 13% last year.
  • RxMx currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$68.3M253N/AN/A-N/A
#2
$11.3M425%N/A-N/A
#3
$33.2M123N/AN/A-N/A
#4
$72.9M2707%N/A-N/A
#5
$29.2M1086%N/A-N/A
#6
$59.4M220N/AN/A-N/A
#7
$20.3M7527%N/A-N/A
#8
$22.4M838%N/A-N/A
#9
$241.7M895N/AN/A-N/A
#10
$13M48-6%N/A-N/A
Missing a competitor? Contribute!?
Submit

Innovation Supporting Medicines RxMx uses systems innovation to re-engineer risk management strategies and patient support for medicines. With origins in Australia, RxMx also operates in the USA and Germany. Traditionally, medicine has been slow to adopt the scale of productivity improvements that other industries take for granted. Our platforms use automated technologies to bridge the gap between pharmaceuticals and real-world risk mitigation; deliver enhanced, efficient patient support programs; and to manage integrated patient reported outcome studies. Founded by four specialist physicians, our driving philosophy is developing medical systems that ensure the safe delivery of complex and sophisticated medicines, with minimal burden on physicians and patients. We offer healthcare organisations three programs that support the use of medicines: RiskMx platform for automated monitoring, alerting and RMP implementation Technology-enabled Patient Support Programs MOD (MObile Data) Patient Reported Outcomes (PRO) platform The RiskMx platform, developed and tested in a clinical trial, bridges the gap between pharmaceuticals and risk mitigation and is built for customisation to any medicine. At its heart, the RiskMx core continuously monitors pathology and other patient-level data using pre-defined algorithms that provide the basis for automated, real-time, healthcare practitioner-friendly REMS/RMP implementation. The MOD (MObile Data) platform is specifically designed to manage PRO studies. It provides a completely automated pipeline using web, SMS and email technologies to generate aggregated, cumulative trial datasets in real-time, without human intervention. Our smart-IT based PSP platform for RxMx Patient and Adherence Support programs complements high quality nursing, providing patient support for new and existing medicines.

keywords:N/A

70

Number of Employees

$18.9M

Revenue (est)

1

Current Jobs

13%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

RxMx News

12/10/2018 - Fast Growing Australian MedTech Startup RxMx Partners with ...

“With InterSystems, RxMx never experience issues with the database. The system just runs and the performance will scale to whatever we need ...

10/25/2018 - NSW's best exporters announced at Premier's awards

Emerging winner: RxMx Australia (Sydney) – medical solutions that enhance the safe use of medicines, optimising patient safety and delivering ...

12/17/2018 - The 2018 eHealth year in review: part one

It later launched a FHIR-enabled version dedicated to the healthcare industry called IRIS for Health, signing up Sydney start-up RxMx to ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$18.9M7021%N/A-N/A
#2
$18.9M7063%N/A-N/A
#3
N/A7013%N/A-N/A
#4
$21.4M708%N/A-N/A
#5
N/A7011%N/A-N/A